Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Blood

• Publication date

  2003-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2002-09-2814PMID 12576335
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Aspects of Blood Viscosity and Cell Deformability

  2012cited by this paper
• High-altitude polycythemia.

  2005cited by this paper
• Erythropoietin‐induced excessive erythrocytosis activates the tissue endothelin system in mice

  2003cited by this paper
• Mutations in the VHL gene in sporadic apparently congenital polycythemia.

  2003cited by this paper
• Stroke at High Altitude: Indian Experience

  2002cited by this paper
• Cerebral transcriptome analysis of transgenic mice overexpressing erythropoietin.

  2002cited by this paper
• Viable c-Kit(W/W) mutants reveal pivotal role for c-kit in the maintenance of lymphopoiesis.

  2002cited by this paper
• Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia

  2002cited by this paper
• Excessive erythrocytosis, chronic mountain sickness, and serum cobalt levels.

  2002cited by this paper
• Hypobaric hypoxia.

  2001cited by this paper
• Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin.

  2001cited by this paper
• Mouse model of congenital polycythemia: Homologous replacement of murine gene by mutant human erythropoietin receptor gene.

  2001cited by this paper
• Increased Cerebral Infarct Volumes in Polyglobulic Mice Overexpressing Erythropoietin

  2001cited by this paper
• Hypobaric hypoxia.

  2001cited by this paper
• Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin.

  2000cited by this paper
• A clinical update in polycythemia vera and essential thrombocythemia.

  2000cited by this paper
• Thromboembolic disease susceptibility related to red cell membrane fluidity in patients with polycythemia vera and effect of phlebotomies.

  1999cited by this paper
• Expression of the thrombopoietin gene in human fetal and neonatal tissues.

  1999cited by this paper
• Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene.

  1999cited by this paper
• Influence of dose-rate on inflammatory damage and adhesion molecule expression after abdominal radiation in the rat.

  1999cited by this paper
• Effect of haemofiltration on pathological fibrinolysis due to severe sepsis: a case report.

  1999cited by this paper
• Study of fibrinolytic parameters in different types of polycythemia

  1999cited by this paper
• Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity.

  1998cited by this paper
• Risk factors of stroke at high and low altitude areas in Saudi Arabia.

  1998cited by this paper
• Congenital polycythemia in Chuvashia.

  1997cited by this paper
• Haematocrit, hypertension and risk of stroke.

  1995cited by this paper
• Regulated basal, inducible, and tissue-specific human erythropoietin gene expression in transgenic mice requires multiple cis DNA sequences.

  1995cited by this paper
• Haematocrit, hypertension and risk of stroke

  1994cited by this paper
• Risk of Stroke in Adults With Cyanotic Congenital Heart Disease

  1993cited by this paper
• Polycythemia vera.

  1992cited by this paper
• Fatal polycythemia induced in mice by dysregulated erythropoietin production by hematopoietic cells.

  1992cited by this paper
• Polycythemia vera.

  1990cited by this paper
• Polycythemia in transgenic mice expressing the human erythropoietin gene.

  1989cited by this paper
• Rheology of the absolute polycythaemias.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Hemodynamic consequences of neonatal polycythemia.

  1987cited by this paper
• 2 Rheology of the absolute polycythaemias

  1987cited by this paper
• High Altitude and Man

  1984cited by this paper
• Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.

  1983cited by this paper
• Studies of β-thromboglobulin, platelet factor 4, and fibrinopeptide a in erythrocytosis due to cyanotic congenital heart disease

  1983cited by this paper
• Haematocrit, Blood Viscosity, Cerebral Blood Flow, and Vascular Occlusion

  1981cited by this paper
• Red blood cells: their dual role in thrombus formation.

  1980cited by this paper
• Haemostatic defects in cyanotic congenital heart disease.

  1979cited by this paper
• VASCULAR OCCLUSIVE EPISODES AND VENOUS HÆMATOCRIT IN PRIMARY PROLIFERATIVE POLYCYTHÆMLX

  1978cited by this paper
• Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia.

  1978cited by this paper
• Evidence for inhibition of platelet activation in blood by a drug effect on erythrocytes

  1976cited by this paper
• Improvement in hemostasis following phlebotomy in cyanotic patients with heart disease.

  1973cited by this paper
• Cerebrovascular accidents in infants and children with cyanotic congenital heart disease.

  1973cited by this paper
• Cerebral vascular accidents in cyanotic congenital heart disease.

  1973cited by this paper
• Hemoglobin and the risk of cerebral infarction: the Framingham Study.

  1972cited by this paper
• Acute Hemodynamic Effects of Red Cell Volume Reduction in Polycythemia of Cyanotic Congenital Heart Disease

  1970cited by this paper
• Acute hemodynamic effects of red cell phoresis in secondary polycythemia with cyanotic congenital heart disease

  1969cited by this paper
• Cerebral lesions in congenital heart disease, a review of autopsies on 162 cases.

  1951cited by this paper
• Cerebral lesions in congenital heart disease.

  1951cited by this paper

• Increased packed cell volume alters point of care viscoelastic clotting parameters in horses

  2024cites this paper
• Decreased Circulating Red Cell Mass Induced by Intravenous Acepromazine Administration Alters Viscoelastic and Traditional Plasma Coagulation Testing Results in Healthy Horses

  2024cites this paper
• Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia

  2024influential citation
• Understanding thrombosis: the critical role of oxidative stress

  2024cites this paper
• Hemoglobin Concentration Impacts Viscoelastic Hemostatic Assays in ICU Admitted Patients*

  2023cites this paper
• Structural and functional changes in erythrocytes associated with the development of thrombosis and disorders of hemostasis

  2022cites this paper
• WHOLE BLOOD THROMBOELASTOGRAPHY IN HEALTHY ADULT CAMELIDS (VICUGNA PACOS AND CAMELUS DROMEDARIUS)

  2022cites this paper
• Differential Effects of Erythropoietin Administration and Overexpression on Venous Thrombosis in Mice

  2022influential citation
• To Investigate Whether Hematocrit Affects Thromboelastography Parameters

  2022cites this paper
• Interaction of von Willebrand factor with blood cells in flow models: a systematic review

  2022cites this paper
• Erythrocytosis in Patients on Testosterone Therapy

  2021cites this paper
• Preoperative hematocrit and platelet count are associated with blood loss during spinal fusion for children with neuromuscular scoliosis

  2021cites this paper
• The adhesion of clots in wounds contributes to hemostasis and can be enhanced by coagulation factor XIII

  2020cites this paper
• Effect of packed red blood cell transfusion on thromboelastographic tracings in dogs with naturally occurring anemia.

  2020cites this paper
• Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis

  2019cites this paper
• Red blood cells: the forgotten player in hemostasis and thrombosis

  2019cites this paper
• Testosterone and Men's Health

  2019cites this paper
• Myomatous erythrocytosis syndrome: A case series

  2019cites this paper
• Modified ROTEM for the detection of rivaroxaban and apixaban anticoagulant activity in whole blood: A diagnostic test study

  2019cites this paper
• Thrombin-antithrombin complex measurement using a point-of-care testing device for diagnosis of disseminated intravascular coagulation in dogs

  2018cites this paper
• Erythrocytosis Following Testosterone Therapy.

  2018cites this paper
• Elevated hematocrit enhances platelet accumulation following vascular injury.

  2017cites this paper
• Thromboelastography as a novel viscoelastic method for hemostasis monitoring: Its methodology, applications, and constraints

  2017cites this paper
• Assessment of coagulation profile by thromboelastometry in adult patients with cyanotic congenital heart disease.

  2016cites this paper
• Treatment with recombinant human erythropoietin

  2015cites this paper
• Haemostatic function and biomarkers of endothelial damage before and after RBC transfusion in patients with haematologic disease

  2015cites this paper
• Prevalence of cerebral and pulmonary thrombosis in patients with cyanotic congenital heart disease

  2015cites this paper
• Thromboelastographic Clot Characteristics of Autologous Equine Blood Products After Activation by Autologous Thrombin, Bovine Thrombin, or Calcium Chloride.

  2015cites this paper
• Effect of fibrinogen on blood coagulation detected by optical coherence tomography

  2015cites this paper
• Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male.

  2015cites this paper
• Neuroprotection with erythropoietin in preterm and/or low birth weight infants.

  2014cites this paper
• High Hematocrit Resulting from Administration of Erythropoiesis-stimulating Agents Is Not Fully Predictive of Mortality or Toxicities in Preclinical Species

  2014cites this paper
• Thromboelastographic Clot Parameters of Autologous Equine Blood Products Activated by Various Clotting Agents

  2014cites this paper
• Thromboelastographic evaluation of hemostatic function in dogs treated for crotalid snake envenomation.

  2014cites this paper
• In vitro hypercoagulability on whole blood thromboelastometry associated with in vivo reduction of circulating red cell mass in dogs.

  2014cites this paper
• Monitoring the blood coagulation process under various flow conditions with optical coherence tomography

  2014cites this paper
• Effects of hematocrit and red blood cell–independent viscosity on canine thromboelastographic tracings

  2014cites this paper
• Dose-related Differences in the Pharmacodynamic and Toxicologic Response to a Novel Hyperglycosylated Analog of Recombinant Human Erythropoietin in Sprague-Dawley Rats with Similarly High Hematocrit

  2014cites this paper
• ERITROCITOSIS PATOLÓGICA DE ALTURA: CARACTERIzACIÓN bIOLÓGICA, DIAGNÓSTICO y TRATAMIENTO. HIGH ALTITUDE PATHOLOGICAL ERyTHROCyTOSIS: bIOLOGICAL CHARACTERIzATION, DIAGNOSIS AND TREATMENT.

  2013cites this paper
• erythrocytosis by regulating blood viscosity Transgenic mice overexpressing erythropoietin adapt to excessive

  2013cites this paper
• The haematocrit--an important factor causing impaired haemostasis in patients with cyanotic congenital heart disease.

  2013cites this paper
• Assessment of coagulation and potential biochemical markers for hypercoagulability in canine hyperadrenocorticism.

  2013cites this paper
• A novel approach for detecting hypercoagulability utilizing thromboelastography.

  2013cites this paper
• Characterization of thrombelastography over time in dogs with hyperadrenocorticism.

  2013cites this paper
• Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease.

  2013cites this paper
• High haematocrit in cyanotic congenital heart disease affects how fibrinogen activity is determined by rotational thromboelastometry.

  2013cites this paper
• Haemoglobin and vascular function in the human retinal vascular bed

  2013cites this paper
• Effect of haematocrit on fibrin-based clot firmness in the FIBTEM test.

  2013cites this paper
• abnormalities but not tumors Chuvash polycythemia VHL mutation with thrombosis and vascular Congenital disorder of oxygen sensing: association of the homozygous

  2013cites this paper
• Hematologic Alterations in Patients with Functionally Univentricular Hearts

  2012cites this paper
• Hemoglobin synthesis, function and metabolism in greyhounds

  2012cites this paper
• Molecular Characterization of the von Hippel-Lindau Tumour Suppressor Protein

  2012cites this paper
• Elevated hematocrit in nonalcoholic fatty liver disease: A potential cause for the increased risk of cardiovascular disease?

  2012cites this paper
• The Effects of Prednisone and Prednisone Plus Ultralow-dose Aspirin on Coagulation Parameters in Healthy Dogs

  2012cites this paper
• Correlation of hematocrit, platelet concentration, and plasma coagulation factors with results of thromboelastometry in canine whole blood samples.

  2012cites this paper
• Effects of acepromazine maleate on platelet function assessed by use of adenosine diphosphate activated- and arachidonic acid- activated modified thromboelastography in healthy dogs.

  2012cites this paper
• Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia

  2011influential citation
• Evaluation of coagulation status in dogs with naturally occurring canine hyperadrenocorticism.

  2011cites this paper
• LOSS OF JAK2 REGULATION VIA VHL-SOCS1 E3 UBIQUITIN HETEROCOMPLEX UNDERLIES CHUVASH POLYCYTHEMIA

  2011cites this paper
• In-vitro hypocoagulability on whole blood thromboelastometry associated with in-vivo expansion of red cell mass in an equine model

  2011cites this paper
• Defining the Thrombotic Risk in Patients with Myeloproliferative Neoplasms

  2011cites this paper
• Clinical pathology of Greyhounds and other sighthounds.

  2011cites this paper
• Hyperviscoucity In Cyanotic Congenital Heart Disease

  2011cites this paper
• Thrombocytosis: Diagnostic Evaluation, Thrombotic Risk Stratification, and Risk-Based Management Strategies

  2011cites this paper
• The influence of platelets, plasma and red blood cells on functional haemostatic assays

  2011cites this paper
• Hypoxia Tolerance in Animals: Biology and Application*

  2010cites this paper
• Application of thrombelastography/thromboelastometry to veterinary medicine.

  2010cites this paper
• Is there a role for erythropoietin in cardiovascular disease?

  2010cites this paper
• Erythropoietin elevates but not voluntary wheel running in mice

  2010cites this paper
• Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms

  2010cites this paper
• Thrombotic Complications of Erythropoiesis-Stimulating Agents

  2010cites this paper
• Thromboelastography in Veterinary Medicine

  2010cites this paper
• Thrombotic complications of erythropoiesis-stimulating agents.

  2010cites this paper
• The role of erythropoietin in the development of pulmonary hypertension

  2009cites this paper
• Optimized surgical techniques and postoperative care improve survival rates and permit accurate telemetric recording in exercising mice

  2009cites this paper
• Therapeutic effects of erythropoietin on histological and functional outcomes following traumatic brain injury in rats are independent of hematocrit.

  2009influential citation
• D-dimer antigen: current concepts and future prospects.

  2009cites this paper
• Global hemostasis testing thromboelastography: old technology, new applications.

  2009cites this paper
• The non‐haematopoietic biological effects of erythropoietin

  2008cites this paper
• Thromboelastographic tracings in retired racing greyhounds and in non-greyhound dogs.

  2008cites this paper
• Postoperative bleeding in retired racing greyhounds.

  2008cites this paper
• Polycythemia Vera — Clinical Aspects

  2007cites this paper
• Reduced Cerebral Blood Flow but Elevated Cerebral Glucose Metabolic Rate in Erythropoietin Overexpressing Transgenic Mice with Excessive Erythrocytosis

  2007cites this paper
• Structure, production and function of erythropoietin: implications for therapeutical use in cardiovascular disease.

  2007cites this paper
• Darbepoetin-Alpha Does Not Promote Microvascular Thrombus Formation in Mice: Role of eNOS-Dependent Protection Through Platelet and Endothelial Cell Deactivation

  2007cites this paper
• Hypoxic preconditioning and erythropoietin protect retinal neurons from degeneration.

  2006cites this paper
• Thrombozytopathie und Blutungskomplikationen bei Urämie

  2006cites this paper
• Ranking the contributing risk factors in venous thrombosis in terms of therapeutic potential: Virchow's triad revisited

  2006cites this paper
• Recombinant human erythropoietin produced in milk of transgenic pigs.

  2006cites this paper
• Vascular Complications in Chuvash Polycythemia

  2006cites this paper
• Etablierung der reduktiven Gasphasenchemilumineszenz zur validen Messung von N-oxiden im Blut von Erythropoetin überexpremierenden Mäusen

  2006cites this paper
• Vascular complications in Chuvash polycythemia.

  2006cites this paper
• [Thrombocytopathy and blood complications in uremia].

  2006cites this paper
• Darbepoetin-α reduziert die Aktivierbarkeit von Thrombozyten in vitro, beeinflusst jedoch nicht die Manifestation mikrovaskulärer Thrombosen in vivo

  2006cites this paper
• Interaktionen von Hypoxie und Hämostase : Hypoxie als prothrombotischer Faktor in der Höhe?

  2005cites this paper
• Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration.

  2005cites this paper
• Potential for Protection and Repair Following Injury to the Developing Brain: A Role for Erythropoietin?

  2005cites this paper
• Congenital erythropoietin over-expression causes “anti-pulmonary hypertensive” structural and functional changes in mice, both in normoxia and hypoxia

  2005cites this paper
• [Interaction of hypoxia and haemostasis--hypoxia as a prothrombotic factor at high altitude?].

  2005cites this paper
• Altered pulmonary vascular reactivity in mice with excessive erythrocytosis.

  2004cites this paper